178
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Combined effects of sivelestat and resveratrol on severe acute pancreatitis-associated lung injury in rats

, , , , &
Pages 288-297 | Received 13 Sep 2013, Accepted 21 Mar 2014, Published online: 02 May 2014

REFERENCES

  • Wang H, Tang AM, Chen L, Zhou M: Potential of sivelestat in protection against severe acute pancreatitis-associated lung injury in rats. Exp Lung Res. 2012;38(9/10):445–452.
  • Bhatia M, Saluja AK, Hofbauer B, Lee H-S, Frossard J-L, Steer ML: The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol. 1998;24(2):77–83.
  • Colon J, Hsieha N, Fergusona A, Kupelian P, Seal S, Jenkins DW, Baker CH: Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomed-Nanotechnol. 2010;6(5):698–705.
  • Rosanna DP, Salvatore C: Reactive oxygen species, inflammation, and lung diseases. Curr Pharm Des. 2012;18(26): 3889–3900.
  • Wang H, Tang AM, Liu D, Li G, Ye L, Li X, Li C, Chen L: Renoprotective activity of sivelestat in severe acute pancreatitis in rats. Exp Ther Med. 2013;6(1):29–32.
  • Sakamaki F, Ishizaka A, Urano T, Sayama K, Nakamura H, Terashima T, Waki Y, Tasaka S, Hasegawa N, Sato K, Nakagawa N, Obata T, Kanazawa M: Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Resp Crit Care. 1996;153(1):391–397.
  • Abraham E: Neutrophils and acute lung injury. Crit Care Med. 2003;31(4 suppl):S195-S199.
  • Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7(1):1–7.
  • Grommes J, Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med. 2011;17(3/4):293–307.
  • Matsumoto S, Shingu C, Koga H, Hidaka S, Goto K, Hagiwara S, Iwasaka H, Noguchi T, Yokoi I: The impact of oxidative stress levels on the clinical effectiveness of sivelestat in treating acute lung injury: an electron spin resonance study. J Trauma. 2010;68(4):796–801.
  • Chung JH, Manganiello V, Dyck JR: Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 2012;22(10):546–554.
  • Ma L, Zhao Y, Li B, Wang Q, Liu X, Chen X, Nan Y, Liang L, Chang R, Liang L, Li P, Jin F: 3,5,4′-Tri-O-acetyl resveratrol attenuates seawater aspiration-induced lung injury by inhibiting activation of nuclear factor-kappa B and hypoxia-inducible factor-1α. Respir Physiol Neurobiol. 2013;185(3):608–614.
  • Rieder SA, Nagarkatti P, Nagarkatti M: Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury. Br J Pharmacol. 2012;167(6):1244–1258.
  • Kawabata K, Hagio T, Matsumoto S, Nakao S, Orita S, Aze Y, Ohno H: Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med. 2000;161(6):2013–2018.
  • Lauer S, Freise H, Fischer LG, Singbartl K, Aken HV, Lerch MM, Sielenkämper AW: The role of thoracic epidural analgesia in receptor-dependent and receptor-independent pulmonary vasoconstriction in experimental pancreatitis. Anesth Analg. 2007;105(2):453–459.
  • Kawabata K, Hagio T, Matsumoto S, Nakao S, Orita S, Aze Y, Ohno H: Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med. 2000;161(6):2013–2018.
  • Elder ASF, Saccone GTP, Bersten AD, Dixon DL: Caerulein-induced acute pancreatitis results in mild lung inflammation and altered respiratory mechanics. Exp. Lung Res. 2011;37(2):69–77.
  • Tanaka A, Minoguchi K, Chen X, Oda N, Yokoe T, Yamamoto Y, Yamamoto M, Watanabe Y, Ohta S, Xu X, Adachi M: Activated protein C attenuates leukocyte elastase-induced lung injury in mice. Shock. 2008;30(2):153–158.
  • Chen P, Zhang Y, Qiao M, Yuan Y: Activated protein C, an anticoagulant polypeptide, ameliorates severe acute pancreatitis via regulation of mitogen-activated protein kinases. J Gastroenterol. 2007;42(11):887–896.
  • Bos M, Gardizi M, Schildhaus H-U, Buettner R, Wolf J: Activated RET and ROS: two new driver mutations in lung adenocarcinoma. Transl Lung Cancer Res. 2013;2(2):112–121.
  • Pelicanoa H, Carney D, Huanga P: ROS stress in cancer cells and therapeutic implications. Drug Resist Update. 2004;7(2):97–110.
  • Kumasaka R, Nakamura N, Fujita T, Murakami R, Shimada M, Osawa H, Yamabe H, Okumura K: Beneficial effect of neutrophil elastase inhibitor on anti-Thy1.1 nephritis in rats. Nephrology. 2008;13(1):27–32.
  • Aune SE, Yeh ST, Kuppusamy P, Kuppusamy ML, Khan M, Angelos MG: Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion. Oxid Med Cell Longev. 2013;2013:279847.
  • Fujimura N, Obara H, Suda K, Takeuchi H, Miyasho T, Kawasako K, Du W, Yamada S, Ono S, Matsumoto K, Matsuda S, Yagi H, Kitago M, Shinoda M, Itano O, Tanabe M, Sakamoto M, Maruyama I, Kitagawa Y: Neutrophil elastase inhibitor improves survival rate after ischemia reperfusion injury caused by supravisceral aortic clamping in rats. J Surg Res. 2013;180(1):E31–E36.
  • Yamaguchi K, Sugasawa Y, Takeuchi K, Kugimiya T, Kumakura S, Iwanuma Y, Kajiyama Y, Tsurumaru M, Nagaoka I, Inada E: Effects of sivelestat on bronchial inflammatory responses after esophagectomy. Int J Mol Med. 2011;28(2):187–192.
  • Takayama M, Ishibashi M, Ishii H, Kuraki T, Nishida T, Yoshida M: Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion. J Appl Physiol. 2001;91(4):1800–1807.
  • Nakano Y, Kondo T, Matsuo R, Murata S, Fukunaga K, Ohkohchi N: Prevention of leukocyte activation by the neutrophil elastase inhibitor, sivelestat, in the hepatic microcirculation after ischemia-reperfusion. J Surg Res. 2009;155(2):311–317.
  • Yoshikawa S, Tsushima K, Koizumi T, Kubo K: Effects of a synthetic protease inhibitor (gabexate mesilate) and a neutrophil elastase inhibitor (sivelestat sodium) on acid-induced lung injury in rats. Eur J Pharmacol. 2010;641(2/3):220–225.
  • Sakashita A, Nishimura Y, Nishiuma T, Takenaka K, Kobayashi K, Kotani Y, Yokoyama M: Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice. Eur J Pharmacol. 2007;571(1):62–71.
  • Toda Y, Takahashi T, Maeshima K, Shimizu H, Inoue K, Morimatsu H, Omori E, Takeuchi M, Akagi R, Morita K: A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. Int J Mol Med. 2007;19(2):237–243.
  • Yamamoto H, Koizumi T, Kaneki T, Hanaoka M, Kubo K: Effects of lecithinized superoxide dismutase and a neutrophil elastase inhibitor (ONO-5046) on hyperoxic lung injury in rat. Eur J Pharmacol. 2000;409(2):179–183.
  • Boueiz A, Damarla M, Hassoun PM: Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):L830–L840.
  • Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, Hassoun PM: Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol Lung Cell Mol Physiol. 1996;271(5):L869–L874.
  • Hassoun PM, Yu FS, Cote CG, Zulueta JJ, Sawhney R, Skinner KA, Skinner HB, Parks DA, Lanzillo JJ: Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia—role in acute lung injury. Am J Respir Crit Care Med. 1998;158(1):299–305.
  • Phan SH, Gannon DE, Ward PA, Karmiol S: Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am J Respir Cell Mol Biol. 1992;6(3):270–278.
  • Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P: Role of xanthine-oxidase and reactive oxygen intermediates in LPS-induced and TNF-induced pulmonary-edema. J Lab Clin Med. 1994;123(3):394–399.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.